Rehstab
Limanowa, Malopolskie Voivodship, 34-600, Poland
NCT Number: NCT04497545
Rehabilitation of lower limbs after a stroke supported by robots aims to return to independence and minimize disability caused by the incident, but the results have been mixed. Objective of the study was to assess the changes in gait capabilities, muscle tone and daily activities in patients after a recent stroke who underwent a 6-week supervised rehabilitation process using exercises on the LUNA EMG neurorehabilitation robot. A total of 60 participants with impaired motor function and gait after subacute stroke were included in the study. Each patient was randomly assigned to an intervention (robot) or control group (RG or CG). All patients, except standard therapy, underwent 1 session of therapy per day, 5 days a week for 6 weeks. People with RG had 30 minutes of training sessions on the Luna EMG robot, while CG received exercises on the lower limb rotor. Patients were evaluated before the start of the study, and then after 2, 4 and 6 weeks of therapy using the Ashworth scale, Rivermead mobility index (RMI), Repty functional index, Time Up and Go test (TUG) and muscle circumference on the thigh.
Looking for future studies?
Notify Me29 year–91 year
All sexes
Interventional
Not applicable
Limanowa, Malopolskie Voivodship, 34-600, Poland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The duration of the overall therapeutic intervention in both groups will be the same.
The duration of the overall therapeutic intervention in both groups will be the same.
Time frame: baseline, after 4 weeks, after 6 weeks
the test is performed from a sitting position. The patient on command is to get up from the chair to walk a distance of 3 meters, then turn back and sit on the chair
Time frame: baseline, after 4 weeks, after 6 weeks
Measurement of resistance during passive knee flexion and extension
Scorse range from 0 to 4, with 5 choices:
Grade 0: No increase in muscle tone. Grade 1: Slight increase in muscle tone, manifested by a catch and release or by minimal.
resistance when the affected part is moved in flexion or extension. Grade 2: More marked increase in muscle tone, but affected part(s) easily moved.
Grade 3: Considerable increase in muscle tone, passive movement difficult. Grade 4: Affected part(s) rigid in flexion or extension. Higher values represent a worse outcome.
Time frame: baseline, after 4 weeks, after 6 weeks
The RMA assess functional mobility following stroke. Gross Function (RMA-Gf) : gait, balance, transfers.
Each item is scored either yes "1" or no "0". It is based on Guttman scaling, which presumes that each subsequent item is of a more difficult nature. To advance to the next question, one must score (1) on an item, otherwise the test is stopped.
Time frame: baseline, after 4 weeks, after 6 weeks
a scoring scale for evaluation of ADL in hemiplegic patients. The higher score the more independent the patient is (the better)
Time frame: baseline, after 4 weeks, after 6 weeks
thigh circumferences (5 and 15 centimeters above the patella),
EGZOTech
Industry
The Influence of EMG-triggered Robotic Movement on Function and Mobility of Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07709806
Brain Diseases, Cardiovascular Diseases
Siping, Jilin, China
View Trial DetailsNCT05734976
Acute, Brain Diseases
Taichung, Taichung North Distrit, Taiwan
View Trial DetailsNCT03684564
Antiphospholipid Syndrome, Autoimmune Diseases
Epsom, United Kingdom
View Trial DetailsNCT06249776
Brain Diseases, Brain Infarction
Ahmedabad, Gujarat, India
View Trial Details